Isabelle Soerjomataram is a medical epidemiologist with a special interest in cancer prevention. She received her medical degree from the University of Indonesia in 2001. Following a PhD in cancer epidemiology (2007) at the Public Health department at Erasmus MC in Rotterdam, she went to the Harvard School of Public Health to work on global indicators of cancer burden. She took a position at IARC in 2011 where she is currently assessing international variation of cancer incidence, mortality and survival investigating the role of risk factors, cancer diagnosis, management and health system, and how policy can impact the cancer burden. She is also members of the steering committee of the COVID and Cancer Global Modeling Consortium, the Every Women Study, co-chair of the Lancet Commission on Cancer and Women and PI of the International Cancer Benchmarking Partnership commissioned study on COVID and Cancer outcome.